Building on established cancer and haematology services
The acquisition builds on Nova Healthcare’s existing services and established consultant relationships in Leeds. It follows Icon Oncology Group’s plans to develop a new Icon Cancer Centre at AMT Headingley Stadium, bringing advanced radiotherapy and oncology imaging closer to home for patients across Leeds and Yorkshire.
Together, Nova Healthcare’s existing cancer and haematology services and Icon Cancer Centre’s planned centre at Headingley offer an opportunity to strengthen specialist care across the region and develop more coordinated pathways over time, working alongside established consultants and healthcare partners.
Mark Middleton, Global CEO, Icon Oncology Group, said:
“Leeds is a major regional hub for cancer care and already plays a vital role in supporting patients from across Yorkshire and the North of England.
“Nova Healthcare has developed important oncology and haematology services, supported by relationships with consultants from a wide range of specialities. We want to build on that full clinical offering, including its highly specialised Gamma Knife service, and support the expertise and relationships that patients already rely on.
“Our immediate priority is continuity for Nova Healthcare’s patients, consultants, teams and healthcare partners. We are committed to working closely with Leeds Teaching Hospitals NHS Trust and local oncology teams to support the best care for patients across the region.”
Specialist Gamma Knife treatment within Nova Healthcare’s wider offering
Alongside its oncology and haematology services, Nova Healthcare operates the specialist Gamma Knife service at Leeds Cancer Centre. Icon has extensive international experience in delivering this highly specialised form of radiotherapy.